Dr. Karl Anderson enjoys a reputation as one of the top Porphyria experts in the world, and has served on the APF Scientific Advisory Board since its inception in 1982.
Dr. Anderson is Associate Director of the General Clinical Research Center (GCRC) at the University of Texas Medical Branch (UTMB) in Galveston, Texas; Director of the Division of Human Nutrition in the Department of Preventive Medicine and Community Health, and a member of the Division of Gastroenterology in the Department of Internal Medicine, and of the Department of Pharmacology and Toxicology. Dr. Anderson also runs both a Porphyria Clinic and a comprehensive diagnostic laboratory for the porphyrias.
Before arriving at UTMB-Galveston in 1987, Dr. Anderson attended the College of Wooster in Ohio and Johns Hopkins University, completed medical residencies at Vanderbilt University and New York Hospital-Cornell Medical Center, and a fellowship at Cornell. Dr. Anderson also spent two years in the Navy doing research on hepatitis B and other tropical diseases in Taiwan, Indonesia and the Philippines. He then served on the faculties at Cornell, Rockefeller University and New York Medical College.
Dr. Anderson's research interests include the effects of diet on drug and hormone metabolism, the human porphyrias and drug metabolism in cirrhosis. Studies underway include new treatments for porphyrias with heme arginate, GnRH analogues and erythropoietin, and the roles of Vitamin C and Hepatitis C in Porphyria Cutanea Tarda. Recent and current sources of grant support include the U.S. FDA Office of Orphan Product Development, the National Institutes of Health, the American Porphyria Foundation, and industry.
Dr. Anderson has given countless hours to ensure that the information the medical information APF distributes is accurate and useful, and has consulted in the care of Porphyria patients throughout the United States and internationally.